The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis

R Kawasaki, M Yasuda, SJ Song, SJ Chen, JB Jonas… - Ophthalmology, 2010 - Elsevier
OBJECTIVE: To determine the prevalence of age-related macular degeneration (AMD) in
Asian populations and to compare this with prevalence in white populations. DESIGN: A …

Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment

AHC Koh, LJ Chen, SJ Chen, Y Chen, A Giridhar, T Iida… - Retina, 2013 - journals.lww.com
Background: Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy
affecting vision, with clinical features distinct from neovascular age-related macular …

Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease

KK Dansingani, C Balaratnasingam, MA Klufas… - American journal of …, 2015 - Elsevier
Purpose To determine the proportion of shallow irregular pigment epithelial detachments in
eyes with pachychoroid features that harbor neovascular tissue and to study the morphology …

Polypoidal choroidal vasculopathy: a review

Y Imamura, M Engelbert, T Iida, KB Freund… - Survey of …, 2010 - Elsevier
More than a quarter century has passed since the original description of polypoidal
choroidal vasculopathy (PCV) in 1982 as a peculiar hemorrhagic disorder involving the …

Photodynamic therapy: current role in the treatment of chorioretinal conditions

DK Newman - Eye, 2016 - nature.com
Verteporfin photodynamic therapy (vPDT) is a selective vaso-occlusive treatment that targets
choroidal vascular abnormalities. It was initially developed to treat neovascular age-related …

Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy

M Cho, IA Barbazetto, KB Freund - American journal of ophthalmology, 2009 - Elsevier
purpose: To describe a neovascular pattern associated with treatment-refractory
neovascular age-related macular degeneration (AMD). DESIGN: A retrospective …

Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy

I Maruko, T Iida, Y Sugano, M Saito, T Sekiryu - American journal of …, 2011 - Elsevier
PURPOSE: To evaluate the morphologic retinal and choroidal changes after verteporfin
photodynamic therapy (PDT) with and without ranibizumab for polypoidal choroidal …

Relationship between pachychoroid and polypoidal choroidal vasculopathy

K Yamashiro, Y Yanagi, H Koizumi… - Journal of Clinical …, 2022 - mdpi.com
Previous clinical studies have suggested that pachychoroid can induce macular
neovascularization (MNV) to develop pachychoroid neovasculopathy (PNV) and that PNV …

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

TYY Lai, WM Chan, DTL Liu, FOJ Luk… - British Journal of …, 2008 - bjo.bmj.com
Aim: To evaluate the efficacy of intravitreal bevacizumab (Avastin) with or without verteporfin
photodynamic therapy (PDT) in the treatment of polypoidal choroidal vasculopathy (PCV) …

Polypoidal choroidal vasculopathy and treatments

F Gomi, Y Tano - Current opinion in ophthalmology, 2008 - journals.lww.com
Although the polypoidal choroidal vasculopathy and age-related macular degeneration
have been known to share common genetic factors, its clinical characteristics including the …